Poseida Therapeutics, Inc. General and Administrative Expense
Poseida Therapeutics, Inc. reported General and Administrative Expense of $10.09 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2024-11-07
- Poseida Therapeutics, Inc. general and administrative expense for the quarter ending 2024-09-30 was $10.09M, a 24.72% increase year-over-year.
- Poseida Therapeutics, Inc. general and administrative expense for the quarter ending 2024-06-30 was $12.18M, a 40.41% increase year-over-year.
- Poseida Therapeutics, Inc. general and administrative expense for the quarter ending 2024-03-31 was $9.80M, a 17.02% decline year-over-year.
- Poseida Therapeutics, Inc. general and administrative expense for the quarter ending 2023-12-31 was $8.86M, a 5.43% decline year-over-year.
- Poseida Therapeutics, Inc. general and administrative expense for fiscal 2023 was $37.44M, a 0.28% decline from fiscal 2022.
- Poseida Therapeutics, Inc. general and administrative expense for fiscal 2022 was $37.54M, a 4.52% increase from fiscal 2021.
- Poseida Therapeutics, Inc. general and administrative expense for fiscal 2021 was $35.91M, a 55.96% increase from fiscal 2020.
- Poseida Therapeutics, Inc. general and administrative expense for fiscal 2020 was $23.03M, a 24.77% increase from fiscal 2019.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $10.09M 10-Q · filed 2024-11-07 | $22.27M derived: sum of 2 quarters · filed 2024-11-07 | $32.07M 10-Q · filed 2024-11-07 | $40.93M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | $12.18M 10-Q · filed 2024-08-05 | $21.98M 10-Q · filed 2024-08-05 | $30.84M derived: sum of 3 quarters · filed 2024-08-05 | $38.93M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-03-31 | $9.80M 10-Q · filed 2024-05-14 | $18.66M derived: sum of 2 quarters · filed 2024-05-14 | $26.75M derived: sum of 3 quarters · filed 2024-11-07 | $35.42M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | $8.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $16.95M derived: sum of 2 quarters · filed 2024-11-07 | $25.63M derived: sum of 3 quarters · filed 2024-11-07 | $37.44M 10-K · filed 2024-03-07 |
| 2023-09-30 | $8.09M 10-Q · filed 2024-11-07 | $16.77M derived: sum of 2 quarters · filed 2024-11-07 | $28.58M 10-Q · filed 2024-11-07 | $37.94M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $8.68M 10-Q · filed 2024-08-05 | $20.48M 10-Q · filed 2024-08-05 | $29.85M derived: sum of 3 quarters · filed 2024-08-05 | $39.24M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $11.81M 10-Q · filed 2024-05-14 | $21.18M derived: sum of 2 quarters · filed 2024-05-14 | $30.56M derived: sum of 3 quarters · filed 2024-05-14 | $39.80M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $9.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $18.76M derived: sum of 2 quarters · filed 2024-03-07 | $27.99M derived: sum of 3 quarters · filed 2024-03-07 | $37.54M 10-K · filed 2024-03-07 |
| 2022-09-30 | $9.39M 10-Q · filed 2023-11-09 | $18.63M derived: sum of 2 quarters · filed 2023-11-09 | $28.17M 10-Q · filed 2023-11-09 | $37.78M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $9.24M 10-Q · filed 2023-08-08 | $18.78M 10-Q · filed 2023-08-08 | $28.39M derived: sum of 3 quarters · filed 2023-08-08 | $37.46M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $9.55M 10-Q · filed 2023-05-09 | $19.16M derived: sum of 2 quarters · filed 2023-05-09 | $28.22M derived: sum of 3 quarters · filed 2023-05-09 | $37.09M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $9.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $18.68M derived: sum of 2 quarters · filed 2023-03-09 | $27.55M derived: sum of 3 quarters · filed 2023-03-09 | $35.91M 10-K · filed 2023-03-09 |
| 2021-09-30 | $9.07M 10-Q · filed 2022-11-10 | $17.94M derived: sum of 2 quarters · filed 2022-11-10 | $26.31M 10-Q · filed 2022-11-10 | $33.78M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $8.87M 10-Q · filed 2022-08-11 | $17.24M 10-Q · filed 2022-08-11 | $24.72M derived: sum of 3 quarters · filed 2022-08-11 | $31.17M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $8.37M 10-Q · filed 2022-05-12 | $15.85M derived: sum of 2 quarters · filed 2022-05-12 | $22.30M derived: sum of 3 quarters · filed 2022-05-12 | $26.54M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $7.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $13.93M derived: sum of 2 quarters · filed 2022-03-10 | $18.17M derived: sum of 3 quarters · filed 2022-03-10 | $23.03M 10-K · filed 2022-03-10 |
| 2020-09-30 | $6.46M 10-Q · filed 2021-11-09 | $10.69M derived: sum of 2 quarters · filed 2021-11-09 | $15.55M 10-Q · filed 2021-11-09 | $19.56M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $4.24M 10-Q · filed 2021-08-12 | $9.09M 10-Q · filed 2021-08-12 | $13.10M derived: sum of 3 quarters · filed 2021-08-12 | $17.11M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $4.85M 10-Q · filed 2021-05-11 | $8.86M derived: sum of 2 quarters · filed 2021-05-11 | $12.87M derived: sum of 3 quarters · filed 2021-05-11 | $16.91M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $8.02M derived: sum of 2 quarters · filed 2021-03-11 | $12.06M derived: sum of 3 quarters · filed 2021-03-11 | $18.46M 10-K · filed 2021-03-11 |
| 2019-09-30 | $4.01M 10-Q · filed 2020-11-12 | $8.05M derived: sum of 2 quarters · filed 2020-11-12 | $14.45M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $4.04M 10-Q · filed 2020-08-20 | $10.44M 10-Q · filed 2020-08-20 |